BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21566453)

  • 1. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
    Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
    Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
    Miyagawa K; Yata Y; Yamaoka N; Sagara Y
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
    Fukada I; Ikeda H; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Kawamoto K; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1733-6. PubMed ID: 19838037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
    Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].
    Akiyama N; Ayata S; Maruyama Y; Tsukada Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1591-3. PubMed ID: 20716894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
    Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
    Fukui H; Kou C; Matsumoto T; Matsumoto M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
    Fujimoto C; Maruyama Y; Niina Y; Fujimori N; Sumii T; Funakoshi A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):1013-6. PubMed ID: 18633236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].
    Kawasaki H; Kukita K; Mizushima Y; Hirata K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1239-42. PubMed ID: 18633272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
    Koga H; Miyoshi A; Nakamura J; Ide T; Kitahara K; Noshiro H
    Gan To Kagaku Ryoho; 2014 May; 41(5):665-8. PubMed ID: 24917019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].
    Sasajima J; Tanno S; Koizumi K; Nakano Y; Habiro A; Chiba A; Fujii T; Sugiyama Y; Nakamura K; Nishikawa T; Mizukami Y; Okumura T; Kohgo Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1657-61. PubMed ID: 19838023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer].
    Shinchi H; Takao S; Maemura K; Noma H; Kitazono M; Ueno S; Sakoda M; Kubo F; Aikou T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1653-6. PubMed ID: 17108735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy].
    Hasegawa K; Katsuta E; Iwata N; Aoyagi H; Yoshida T; Takahata T; Kaneko J; Maejima S
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2152-4. PubMed ID: 22202313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
    Tokairin Y; Iida M; Yamazaki S
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy].
    Kawamoto K; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Niwano M; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1131-4. PubMed ID: 17637556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].
    Nakamoto Y; Ogata M; Yamamoto M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1979-81. PubMed ID: 20948268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
    Ohta H; Doi T; Kikuchi S; Sato Y; Okuda T; Fujimi A; Kanisawa Y; Izumi K; Kitahara T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1489-92. PubMed ID: 17876153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.
    Suzuki S; Ozaki Y; Saida S; Kaji S; Koike N; Harada N; Hayashi T; Suzuki M
    Hepatogastroenterology; 2013 Jun; 60(124):916-20. PubMed ID: 23478143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.